George V. Migausky - Aug 20, 2021 Form 4 Insider Report for Immunovant, Inc. (IMVT)

Role: Director
Signature: /s/ Pamela Yanchik Connealy, attorney-in-fact for George V. Migausky
Stock symbol: IMVT
Transactions as of: Aug 20, 2021
Transactions value $: $53,550
Form type: 4
Date filed: 8/20/2021, 06:14 PM
Next filing: Sep 8, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IMVT	Common Stock	Purchase	$53.6K	+7K	+11.63%	$7.65	67.2K	Aug 20, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.64 - $7.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.

Content

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.64 - $7.68, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote to this Form 4.